ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

SMMT Summit Therapeutics Inc

4.48
0.09 (2.05%)
2024年5月7日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Summit Therapeutics Inc SMMT NASDAQ Depository Receipt
  前日比 前日比 % 現在値 時刻
0.09 2.05% 4.48 07:41:10
始値 安値 高値 終値 前日終値
4.40 4.32 4.57 4.47 4.39
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0120:00BWSummit Therapeutics Reports Financial Results and..
2024/4/2505:30BWSummit Therapeutics to Host First Quarter 2024 Financial..
2024/4/1205:30BWSummit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned..
2024/4/1020:00BWSummit Therapeutics to Present at the Stifel 2024 Targeted..
2024/3/2220:00BWPromising Intracranial Anti-Tumor Activity and Safety Data..
2024/3/1420:00BWIntracranial Anti-Tumor Activity and Safety of Ivonescimab..
2024/3/0606:05EDGAR2Form 8-K - Current report
2024/3/0521:00BWSummit Therapeutics to Present at the Barclays 26th Annual..
2024/2/2022:05EDGAR2Form 8-K - Current report
2024/2/2021:55EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/2/2021:32EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2021:00BWSummit Therapeutics Reports Financial Results and..
2024/2/1607:25EDGAR2Form 8-K - Current report
2024/2/1506:35EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
2024/2/1500:29BWSummit Therapeutics to Host Fourth Quarter & Full Year 2023..
2024/2/1421:00BWSummit Therapeutics to Host Fourth Quarter & Full Year 2023
2024/2/0721:00BWSummit Therapeutics to Present at Oppenheimer’s 34th Annual..
2024/1/0823:07EDGAR2Form 8-K - Current report
2024/1/0823:00BWSummit Therapeutics Announces Updated Phase II Data for..
2024/1/0506:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:06EDGAR2Form 8-K - Current report
2024/1/0321:30BWSummit Therapeutics to Present at the 42nd Annual J.P...
2023/12/1406:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0722:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0722:03EDGAR2Form 8-K - Current report
2023/11/0721:00BWSummit Therapeutics Reports Financial Results and..
2023/11/0305:41BWLaura Chow, MD, Cancer Immunotherapy Trailblazer, Joins..
2023/11/0105:02EDGAR2Form 8-K - Current report
2023/10/3121:00BWIvonescimab’s Novel Mechanism of Action Highlighting..
2023/10/2621:00BWSummit Therapeutics to Host Q3 2023 Financial Results &..
2023/10/1921:00BWH. Jack West, MD, Renowned Oncologist & Lung Cancer Expert,..
2023/10/1620:46EDGAR2Form 8-K - Current report
2023/10/1620:00BWSummit Therapeutics Appoints Proven Biotech Leader Manmeet..
2023/9/2004:40EDGAR2Form DEF 14A - Other definitive proxy statements
2023/9/0905:08EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/8/1005:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0921:03EDGAR2Form 8-K - Current report
2023/8/0920:00BWSummit Therapeutics Reports Financial Results and..
2023/8/0305:05EDGAR2Form 8-K - Current report
2023/8/0221:00BWSummit Therapeutics to Host Q2 2023 Financial Results &..
2023/6/0421:00BWPromising Data for Investigational Innovative Bispecific..
2023/6/0120:30BWIvonescimab Updated Data to be Featured at ASCO 2023
2023/5/1120:30BWSummit Therapeutics Reports Financial Results and..
2023/5/0920:30BWSummit Therapeutics Announces First Patient Treated in Phase..

最近閲覧した銘柄

Delayed Upgrade Clock